Topics

Latest "Diagnostics" News Stories

00:56 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "Diagnostics" found in our extensive news archives from over 250 global news sources.

More Information about Diagnostics on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Diagnostics for you to read. Along with our medical data and news we also list Diagnostics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Diagnostics Companies for you to search.

Showing "Diagnostics" News Articles 1–25 of 1,900+

Relevant

Todos Medical to buy in vitro diagnostics company Provista Diagnostics

Todos Medical has agreed to acquire in vitro diagnostics company Provista Diagnostics for an undisclosed sum. Provista is involved in the development and commercialisation of blood-based proteomic diagnostic, The post Todos Medical to buy in vitro diagnostics company Provista Diagnostics appeared first on NS Medical Devices.


EKF Diagnostics opens new R&D facility in UK

EKF Diagnostics, the global in vitro diagnostics company, announces that it has opened a new Research & Development facility at its Cardiff, UK headquarters. The new Special Projects Laboratory will focus on developing new applications for EKF’s many point-of-care and central laboratory medical products to enable the Company to enter new market sectors, as well as providing additional di...

Molecular Diagnostics Picks Up the Pace

Kalorama Information estimates that the market for molecular diagnostics is worth $8.7 billion and will reach $12.9 billion by 2024, outpacing growth in traditional in vitro diagnostics. The post Molecular Diagnostics Picks Up the Pace appeared first on GEN - Genetic Engineering and Biotechnology News.


The World Molecular Diagnostics Market, 2019 Edition – Focus on CT/NG, HPV, Hepatitis, HIV, HAIs, Respiratory Diseases, and Tuberculosis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The World Molecular Diagnostics Market, 8th Edition” report has been added to ResearchAndMarkets.com’s offering. Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has … Continue reading →

VC firm brings in $12.5M for Specific Diagnostics

Venture capital firm Telegraph Hill Partners has provided $12.5 million for in vitro diagnostics firm Specific Diagnostics.  -More- 

Hardy Diagnostics introduces NG-Test CARBA 5 for detection of Carbapenemases

Hardy Diagnostics, an FDA-licensed and ISO-certified biomedical manufacturer, has formed a partnership with NG Biotech in France. Hardy Diagnostics is now the United States’ authorized distributor of NG The post Hardy Diagnostics introduces NG-Test CARBA 5 for detection of Carbapenemases appeared first on NS Medical Devices.

CoSara, Co-Diagnostics to debut IVDs in India

CoSara Diagnostics and Co-Diagnostics will launch their CoSara in vitro diagnostic products in India beginning Saturday.  -More- 

3D Med Diagnosis Completes a $40 Million Initial Funding for Cancer Diagnostics

3D Med Diagnosis, a recent diagnostics spin-off from 3D Medicines, raised $40 million in its debut funding. 3D Medicines was established in 2010 to concentrate on the three D's cancer care: diagnostics, drugs and data. 3D Med Diagnosis owns the company's diagnostics portfolio that offers next-gen sequencing for early-stage cancer detection and precision medicine diagnosis. Its cancer diagnostics i...

Chembio to buy Brazilian point-of-care diagnostics company Orangelife

Chembio Diagnostics has agreed to acquire Brazilian point-of-care diagnostics company Orangelife Comercio e Industria. Orangelife is involved in the manufacturing and distribution of point-of-care diagnostics tests for infectious The post Chembio to buy Brazilian point-of-care diagnostics company Orangelife appeared first on NS Medical Devices.

Molzym is Part of Gradian Diagnostics

Gradian Diagnostics announced that Molzym GmbH & Co. KG is joining Gradian Diagnostics. Molzym will become the first acquisition, bringing a wide set of products and services due to their wealth of experience and expertise in molecular microbial analysis, and their focus on deep research and automat...

Coordinator Digital Health Accelerator

Location: Penzberg, Germany Job Type: Full-Time Employer: Roche Roche Diagnostics is the leading provider of in vitro diagnostics. We have the ambition to continue shaping the industry by developing and providing innovative solutions...

NeuMoDx inks molecular diagnostic deal with Sentinel Diagnostics

NeuMoDx Molecular has agreed to work with Sentinel Diagnostics to develop molecular diagnostics assays for respiratory infect -More- 

Lab21 acquires Omega Diagnostics' infectious disease biz for up to £2.18mm

Novacyt SA’s protein diagnostics subsidiary Lab21 Ltd. is acquiring Omega Diagnostics Ltd.’s infectious disease business ...

Gilead’s Matthew Sause to Join Roche Diagnostics as North America CEO

Roche Diagnostics has appointed Matthew Sause to serve as president and CEO of its North America operations. Sause is coming to Indianapolis-based Roche Diagnostics from Gilead Sciences (NASDAQ: GILD), where he is senior vice president and head of global commercial product. His experience includes 17 years at Roche, including time at the company’s diagnostics division. […]

Top Ten Insights for Digital Health Innovators from the Next Generation Point of Care Diagnostics Conference

Cambridge HealthTech Institute (CHI) invited me to attend their Next Generation Point of Care Diagnostics Conference and I came away thoroughly impressed with the content, speakers, and organization. Since I chair several conferences a year I know how hard it is to pull off a good one so I’d like to thank CHI for a job well done. Goals & Attendees The goal of the event was to provide a p...

EKF Diagnostics opens new Research & Development facility at Cardiff HQ

EKF Diagnostics, the global in vitro diagnostics company, announces that it has opened a new Research & Development facility at its Cardiff, UK headquarters.

Co-Diagnostics introduces CoPrimer test for 2019-nCoV coronavirus

Molecular diagnostics firm Co-Diagnostics has introduced its CoPrimer test for the 2019-nCoV coronavirus. The research use only (RUO) test can be used by appropriate laboratories, hospitals, and institutions The post Co-Diagnostics introduces CoPrimer test for 2019-nCoV coronavirus appeared first on NS Medical Devices.

Asuragen and Wave partner to develop companion diagnostics for Huntington’s disease

Molecular diagnostics firm Asuragen has collaborated with clinical-stage genetic medicines company Wave Life Sciences to develop companion diagnostics for Huntington’s disease (HD). As part of the agreement, the The post Asuragen and Wave partner to develop companion diagnostics for Huntington’s disease appeared first on NS Medical Devices.

Genecast (Beijing) and US-based Interpace Form Diagnostics Partnership

Genecast (Beijing) Biotech, a cancer diagnostics company, partnered with Interpace Diagnostics of New Jersey to offer translational studies and clinical trial diagnostics to biopharma companies. According to the agreement, Interpace will offer the diagnostic products/services worldwide except in China, where Genecast will be responsible for them. Founded in 2014, Genecast has developed circulating...

Novacyt, Co-Diagnostics, Other Test Firms Seek Fast-Track EUA Approval From FDA For Coronavirus Dx's

Diagnostics companies around the world – including Novacyt, Roche, Co-Diagnostics and Mammoth Biosciences – are developing and launching tests to...   

Exact Sciences and Genomic Health Merge to Form Leading Cancer Diagnostics Company

The combined companies will have revenue drivers of two commercially available diagnostics tools, Cologuard and Oncotype DX.

Product Owner Digital Health Solutions

Location: Zug, Rotkreuz, Switzerland Job Type: Full-Time Employer: Roche Roche Diagnostics is the #1 IVD company globally. The biggest Business Area of Roche Diagnostics - Centralized and Point of Care Solutions (CPS), has the ambiti...

FDA to promote development of coronavirus diagnostics and countermeasures

C2N Diagnostics’ APTUS-Aβ Blood Test for Alzheimer’s yields positive results

C2N Diagnostics has unveiled positive results from a study of its APTUS-Aβ blood test for identifying the existence of Alzheimer’s pathology in the brain. The diagnostics company said The post C2N Diagnostics’ APTUS-Aβ Blood Test for Alzheimer’s yields positive results appeared first on NS Medical Devices.

RUO test for novel coronavirus launched by Co-Diagnostics

The Logix Smart 2019-nCoV research use only test has been introduced by Co-Diagnostics for use in hospitals, labs and other i -More- 


Quick Search

News Quicklinks